Kairos Pharma, Ltd. ( KAPA) - Stock Earnings
KAPA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
KAPA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.4 million USD | — USD |
| 2026Q1 | -1.7 million USD | — USD |
| 2026Q2 | -1.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KAPA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.8 million USD | — USD |
| 2024 | -2.6 million USD | — USD |
| 2025 | -5.4 million USD | — USD |
| 2026 Est. | — | — |
KAPA
Price: $0.60
52 week price:
Earnings Per Share: -0.27 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.8 million